Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P; NF France Network.

Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3.

2.

Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).

Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses.

Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7.

3.

[Neurofibromatosis type 1 or Von Recklinghausen's disease].

Pinson S, Wolkenstein P.

Rev Med Interne. 2005 Mar;26(3):196-215. Review. French.

PMID:
15777582
4.

[Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment].

Chiaverini C, Bourrat E, Mazereeuw-Hautier J, Hadj-Rabia S, Bodemer C, Lacour JP.

Ann Dermatol Venereol. 2017 Jan;144(1):6-35. doi: 10.1016/j.annder.2016.07.016. Epub 2016 Dec 5. French.

PMID:
27931749
5.

Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K.

Genet Med. 2018 Jul;20(7):671-682. doi: 10.1038/gim.2018.28. Epub 2018 Apr 26.

PMID:
30006586
6.

Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.

Kokkinou E, Roka K, Alexopoulos A, Tsina E, Nikas I, Krallis P, Thanopoulou I, Nasi L, Makrygianni E, Tsoutsou E, Kosma K, Tsipi M, Tzetis M, Frysira H, Kattamis A, Pons R.

Postgrad Med. 2019 Sep;131(7):445-452. doi: 10.1080/00325481.2019.1659708. Epub 2019 Sep 12.

PMID:
31443616
7.

Public health and evidence-informed policy-making: The case of a commonly used herbicide.

Vainio H.

Scand J Work Environ Health. 2020 Jan 1;46(1):105-109. doi: 10.5271/sjweh.3851. Epub 2019 Sep 5.

PMID:
31486846
8.

Metastatic malignant peripheral nerve sheath tumor in neurofibromatosis type 1: a geriatric patient report.

Firat C, Aytekin AH, Erbatur S.

Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1301-4.

10.

The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.

Walter H, Sadeque-Iqbal F, Ulysse R, Castillo D, Fitzpatrick A, Singleton J.

JBI Database System Rev Implement Rep. 2015 Oct;13(10):69-81. doi: 10.11124/jbisrir-2015-2335.

PMID:
26571284
11.
12.

Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.

Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE, Tabori U.

Clin Cancer Res. 2017 Jun 15;23(12):e46-e53. doi: 10.1158/1078-0432.CCR-17-0589. Review.

13.

An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.

Hernández-Martín A, Duat-Rodríguez A.

Actas Dermosifiliogr. 2016 Jul-Aug;107(6):465-73. doi: 10.1016/j.ad.2016.01.009. Epub 2016 Mar 5. Review. English, Spanish.

PMID:
26956402
14.

Sepsis Care Pathway 2019.

Labib A.

Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

15.

International guidelines for groin hernia management.

HerniaSurge Group.

Hernia. 2018 Feb;22(1):1-165. doi: 10.1007/s10029-017-1668-x. Epub 2018 Jan 12.

16.

Neurological complications of neurofibromatosis type 1 in adulthood.

Créange A, Zeller J, Rostaing-Rigattieri S, Brugières P, Degos JD, Revuz J, Wolkenstein P.

Brain. 1999 Mar;122 ( Pt 3):473-81.

PMID:
10094256
18.

Treatment of neurofibromatosis type 1.

Sabatini C, Milani D, Menni F, Tadini G, Esposito S.

Curr Treat Options Neurol. 2015 Jun;17(6):355. doi: 10.1007/s11940-015-0355-4.

PMID:
25917340
19.

Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.

Monroe CL, Dahiya S, Gutmann DH.

Annu Rev Pathol. 2017 Jan 24;12:53-74. doi: 10.1146/annurev-pathol-052016-100228. Review.

PMID:
28135565
20.

Neurological malignancies in neurofibromatosis type 1.

Eoli M, Saletti V, Finocchiaro G.

Curr Opin Oncol. 2019 Nov;31(6):554-561. doi: 10.1097/CCO.0000000000000576.

PMID:
31436563

Supplemental Content

Support Center